N° of CRKP colonized patients |
11 |
8 |
|
Male |
5 (45%) |
8 (100%) |
|
Female |
6 (54%) |
0 |
0.01 |
Underlying disease |
Acute leukemia |
10 (91%) |
3 (37.5%) |
0.0075 |
Acute myeloid leukemia |
9 (82%) |
0 |
0.0007 |
Other haematological malignancy |
1 (9%) |
5 (62.5%) |
ns |
Chemotherapy |
7 (64%) |
5 (62.5%) |
ns |
- Intensive induction chemotherapy |
6 (54%) |
0 |
0.01 |
n° of patients with <1000 neutrophils/mm3 at CRKP acquisition |
5 (45%) |
4 (50%) |
ns |
n° of patients with <100 neutrophils/mm3 at CRKP acquisition |
4 (36%) |
3 (37%) |
ns |
Days spent colonized by CRKP with: |
< 1000 neutrophils/mm3, mean, median (range) |
14.8, 10 (0–78) |
10.7, 5.5 (0–30) |
<0.01 |
< 100 neutrophils/mm3, mean, median (range) |
9.1, 8 (0–30) |
5.6, 3 (0–15) |
<0.01 |
Rectal colonization |
11 (100%) |
8 (100%) |
ns |
Single site colonization |
4 (36%) |
5 (62.5%) |
ns |
Multiple sites colonization |
7 (64%) |
3 (37%) |
ns |
Colonized sites besides the rectum |
vagina/urethra |
3 |
0 |
|
urinary tract |
5 |
2 |
|
oral cavity, pharynx |
2 |
2 |
|
Mucositis |
6 (54%) |
3 (37%) |
ns |
- Diarrea |
6 |
3 |
|
CRKP localized infection |
7 (64%) |
3 (37.5%) |
ns |
vaginitis |
3 |
0 |
ns |
typhlitis |
2 |
1 |
|
hemorroidal cellulitis |
2 |
1 |
|
cellulitis |
0 |
1 |
|
Previous febrile neutropenia during CRKP colonization |
6 |
3 |
ns |
Previous bacteremia other than CRKP bacteremia during CRKP colonization |
4 |
2 |
ns |
Previous broad-spectrum antibiotics during CRKP colonization |
5 |
4 |
ns |